Correlation Between Praxis Precision and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Entero Therapeutics,, you can compare the effects of market volatilities on Praxis Precision and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Entero Therapeutics,.
Diversification Opportunities for Praxis Precision and Entero Therapeutics,
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Praxis and Entero is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Praxis Precision i.e., Praxis Precision and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Praxis Precision and Entero Therapeutics,
Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.47 times more return on investment than Entero Therapeutics,. However, Praxis Precision Medicines is 2.14 times less risky than Entero Therapeutics,. It trades about 0.14 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.04 per unit of risk. If you would invest 1,820 in Praxis Precision Medicines on August 26, 2024 and sell it today you would earn a total of 5,630 from holding Praxis Precision Medicines or generate 309.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. Entero Therapeutics,
Performance |
| Timeline |
| Praxis Precision Med |
| Entero Therapeutics, |
Praxis Precision and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and Entero Therapeutics,
The main advantage of trading using opposite Praxis Precision and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Praxis Precision vs. Molecular Partners AG | Praxis Precision vs. Mineralys Therapeutics, Common | Praxis Precision vs. AN2 Therapeutics | Praxis Precision vs. Pharvaris BV |
| Entero Therapeutics, vs. Cardinal Health | Entero Therapeutics, vs. Inflection Point Acquisition | Entero Therapeutics, vs. Aquestive Therapeutics | Entero Therapeutics, vs. Mangazeya Mining |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |